NA

ID: ALA4787652

Chembl Id: CHEMBL4787652

PubChem CID: 162667963

Max Phase: Preclinical

Molecular Formula: C26H35NO4

Molecular Weight: 425.57

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCC[C@](C)(O)[C@H]1CC23C=C[C@]1(OC)[C@H]1Oc4c(OC)ccc5c4[C@]12CCN(C)[C@@H]3C5

Standard InChI:  InChI=1S/C26H35NO4/c1-6-9-23(2,28)18-15-24-10-11-26(18,30-5)22-25(24)12-13-27(3)19(24)14-16-7-8-17(29-4)21(31-22)20(16)25/h7-8,10-11,18-19,22,28H,6,9,12-15H2,1-5H3/t18-,19-,22+,23+,24?,25-,26-/m1/s1

Standard InChI Key:  LOOHQOHHYOAWOS-ZANKGHLHSA-N

Alternative Forms

  1. Parent:

    ALA4787652

    ---

Associated Targets(non-human)

Oprm1 Mu opioid receptor (6060 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Oprd1 Delta opioid receptor (3911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Kappa opioid receptor (4577 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Oprd1 Opioid receptors; mu & delta (878 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 425.57Molecular Weight (Monoisotopic): 425.2566AlogP: 3.47#Rotatable Bonds: 5
Polar Surface Area: 51.16Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.03CX LogP: 2.89CX LogD: 1.26
Aromatic Rings: 1Heavy Atoms: 31QED Weighted: 0.73Np Likeness Score: 1.76

References

1. Szűcs E,Marton J,Szabó Z,Hosztafi S,Kékesi G,Tuboly G,Bánki L,Horváth G,Szabó PT,Tömböly C,Varga ZK,Benyhe S,Ötvös F.  (2020)  Synthesis, biochemical, pharmacological characterization and in silico profile modelling of highly potent opioid orvinol and thevinol derivatives.,  191  [PMID:32092588] [10.1016/j.ejmech.2020.112145]

Source